WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Inovio Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jacqueline Elizabeth SheaChief Executive Officer2024-02-26872$8.16
$7.12kSell
Laurent HumeauChief Scientific Officer2024-02-26770$8.16
$6.28kSell
Peter KiesCFO2024-02-262,358$8.16
$19.24kSell
Peter KiesCFO2024-02-261,108$8.16
$9.04kSell
Laurent HumeauChief Scientific Officer2024-02-261,581$8.16
$12.90kSell
Jacqueline Elizabeth SheaChief Executive Officer2024-02-262,856$8.16
$23.30kSell
Lota S. ZothDirector2023-06-055,700$0.56
$3.19kSell
Jacqueline Elizabeth SheaChief Executive Officer2023-05-1028,704$0.81
$23.25kSell

1 of 1

INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INO insiders and whales buy or sell their stock.

INO Shareholders

What type of owners hold Inovio Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe88.36%20,650,987$218.28MInsider
Vanguard Group Inc84.58%19,766,062$208.93MInstitution
Renaissance Technologies LLC31.22%7,297,379$77.13MInstitution
Tee Khiang Ng20.97%4,899,931$51.79MInsider
Blackrock Inc16.83%3,932,564$41.57MInstitution
Gsa Capital Partners LLP16.25%3,796,529$40.13MInstitution
Geode Capital Management LLC12.29%2,871,445$30.35MInstitution
D E Shaw Co Inc11.56%2,701,162$28.55MInstitution
Jong Joseph Kim10.04%2,346,000$24.80MInsider
Jacobs Levy Equity Management Inc4.92%1,149,974$12.16MInstitution

1 of 3

INO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INO61.56%38.44%Net SellingNet Selling
XERS42.66%15.51%Net BuyingNet Buying
AGEN63.15%36.85%Net BuyingNet Buying
FENC4.18%95.82%Net BuyingNet Selling
PYXS15.13%36.17%Net Selling
View Top Biotech Stocks

Inovio Pharmaceuticals Stock Ownership FAQ

Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 214.70% institutional shareholders, 134.08% Inovio Pharmaceuticals insiders, and 0.00% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 88.36% of the company. Austin W. Greenhouse David M. Marxe's Inovio Pharmaceuticals shares are currently valued at $218.28M.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.